Observational × Lymphoma, Large B-Cell, Diffuse × Clear all NEURO_CAR-T
Not yet recruiting
100 enrolled
Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
Enrolling by invitation
120 enrolled
GlofitReal
Recruiting
300 enrolled
Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes
Completed
60 enrolled
Long-term Follow up Local Registry Study of Kymriah in South Korea
Recruiting
500 enrolled
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Recruiting
30 enrolled
Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
Recruiting
200 enrolled
EPKEY_HSR
Active not recruiting
150 enrolled
A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma
Active not recruiting
1,000 enrolled
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
Active not recruiting
153 enrolled
RUBIN
Recruiting
2,950 enrolled
Treatment and Outcomes of DLBCL After Progression on Polatuzumab Vedotin-based Combination Therapy
Not yet recruiting
200 enrolled
FIL_MIMYC
Recruiting
200 enrolled
Metabolic and Immunomic Differential Analysis of Primary Central Nervous System Diffuse Large B-Cell Lymphoma
Recruiting
20 enrolled
Drug-Eluting Bead-Based Transarterial Chemoembolization (DEB-TACE) as a Local Salvage Therapy for Large Lesions in Relapsed and Refractory Diffuse Large B-Cell Lymphoma
Recruiting
10 enrolled
Long-term Follow-up Study of Patients Receiving CAR-T Cells
Recruiting
500 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
Bio-CAR-T BS Study
Recruiting
45 enrolled
Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
Recruiting
45 enrolled
Study on Predicting Response to Standard First-Line Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using ctDNA Combined With PET
Recruiting
300 enrolled
Clinical Follow-up Study of CD19 CAR-T Expressing IL7 and CCL19 for Relapsed or Refractory B Cell Lymphoma
Completed
39 enrolled
Registry of Older Patients With Cancer
Recruiting
3,000 enrolled
Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies
Recruiting
200 enrolled
Brazilian Reality in the Diagnosis and Treatment of Diffuse Large B Cell Lymphoma - BRA-DLBCL
Completed
600 enrolled
Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy
Recruiting
49 enrolled
SANGUINE
Recruiting
3,000 enrolled
Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study
Terminated
36 enrolled
REVERSE_2021
Recruiting
50 enrolled
TALOs
Recruiting
96 enrolled
Understanding the Role of Large Extracellular Vesicles in Lymphomas and Lymphoproliferative Disorders: the "Off the Beaten Track" Liquid Biopsy
Completed
102 enrolled
Comparison of Whole-body MRI, Circulating DNA and PET-CT in Staging, Prognosis, and Treatment Response in Patients with Diffuse Large Cell B Lymphoma
Completed
14 enrolled
PIXBRIDGE
Active not recruiting
15 enrolled
The Microbiome in Blood Cancer and HLH
Not yet recruiting
750 enrolled
realMIND
Recruiting
100 enrolled
The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter Study
Not yet recruiting
200 enrolled
DEL Biomarker
Not yet recruiting
400 enrolled
PC002
Not yet recruiting
210 enrolled
MOSAIC
Recruiting
7,000 enrolled
A Real-World Study on Extranodal Lymphoma
Not yet recruiting
5,000 enrolled
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas
Completed
203 enrolled
Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy
Recruiting
300 enrolled
A Retrospective Study on Extranodal DLBCL
Completed
5,023 enrolled
Characterization and Clinical Impact of the Gut Microbiota in Lymphoma
Recruiting
200 enrolled
Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.
Terminated
3 enrolled
Study of the Hematopoietic Niche and the Role of Inflammation in the Pathophysiology of Cytopenias After CAR-T Cell Therapy: Potential of Therapies Directed to Repair the Bone Marrow Microenvironment
Recruiting
40 enrolled
Care Pathway and Associated Costs of Patients Treated With CAR T-cells Based on SNDS Data
Completed
602 enrolled
The Potential of Patient-reported Outcome Measures in Detection of Relapse in Diffuse Large B-cell Lymphoma
Completed
250 enrolled
Real-World HRU and Costs in DLBCL Pts With Tisa-cel and Axi-cel, a Medicare Study.
Completed
613 enrolled
Preliminary Assessment of [18F]BL40 in PET/CT Scans
Unknown
30 enrolled
PROSECO
Completed
592 enrolled